Do analysts prefer BMRA or LUCY?

Biomerica presently has a consensus target price of $9.00, indicating a potential upside of 452.15%. Given Biomerica's higher possible upside, equities analysts plainly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher valuation & earnings, BMRA or NXGL?

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $5.31M 0.95 -$4.97M -$0.89 N/A NexGel $11.42M 0.29 -$3M -$0.40 N/A

Is BMRA or NXGL more profitable?

NexGel has a net margin of -28.54% compared to Biomerica's net margin of -96.49%. NexGel's return on equity of -64.29% beat Biomerica's return on equity. Company Net Margins Return on Equity Return on Assets Biomerica -96.49% -98.14% -70.42% NexGel -28.54% -64.29% -29.64%

Do analysts recommend CUPR or BMRA?

Biomerica has a consensus target price of $9.00, indicating a potential upside of 452.15%. Given Biomerica's higher probable upside, analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, CUPR or BMRA?

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 69.92 -$3.63M N/A N/A Biomerica $5.31M 0.95 -$4.97M -$0.89 N/A

Do analysts prefer LUCYW or BMRA?

Biomerica has a consensus price target of $9.00, indicating a potential upside of 452.15%. Given Biomerica's stronger consensus rating and higher probable upside, analysts plainly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, LUCYW or BMRA?

Innovative Eyewear has higher earnings, but lower revenue than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Innovative Eyewear $2.98M N/A N/A N/A N/A Biomerica $5.31M 0.95 -$4.97M -$0.89 N/A

Do analysts recommend BMRA or NXGLW?

Biomerica presently has a consensus target price of $9.00, suggesting a potential upside of 452.15%. Given Biomerica's stronger consensus rating and higher probable upside, equities analysts clearly believe Biomerica is more favorable than NEXGEL. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, BMRA or NXGLW?

NEXGEL has higher revenue and earnings than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $5.31M 0.95 -$4.97M -$0.89 N/A NEXGEL $11.27M N/A N/A N/A N/A

Is BMRA or NXGLW more profitable?

NEXGEL has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. NEXGEL's return on equity of 0.00% beat Biomerica's return on equity. Company Net Margins Return on Equity Return on Assets Biomerica -96.49% -98.14% -70.42% NEXGEL N/A N/A N/A

Biomerica (BMRA) Competitors

$1.63 +0.02 (+1.24%)

As of 04:00 PM Eastern

Compare

BMRA vs. LUCY, NXGL, CUPR, LUCYW, and NXGLW

Should you buy Biomerica stock or one of its competitors? Biomerica's main competitors and comparable companies include Innovative Eyewear (LUCY), NexGel (NXGL), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCYW), and NEXGEL (NXGLW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Biomerica compare to Innovative Eyewear?

Biomerica (NASDAQ:BMRA) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Biomerica has higher revenue and earnings than Innovative Eyewear. Biomerica is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$5.31M	0.95	-$4.97M	-$0.89	N/A
Innovative Eyewear	$2.66M	1.68	-$7.59M	-$1.69	N/A

22.3% of Biomerica shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 18.0% of Biomerica shares are owned by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Biomerica has a net margin of -96.49% compared to Innovative Eyewear's net margin of -272.42%. Innovative Eyewear's return on equity of -83.37% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-96.49%	-98.14%	-70.42%
Innovative Eyewear	-272.42%	-83.37%	-76.02%

In the previous week, Innovative Eyewear had 1 more articles in the media than Biomerica. MarketBeat recorded 1 mentions for Innovative Eyewear and 0 mentions for Biomerica. Biomerica's average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company	Overall Sentiment
Biomerica	Neutral
Innovative Eyewear	Neutral

Biomerica presently has a consensus target price of $9.00, indicating a potential upside of 452.15%. Given Biomerica's higher possible upside, equities analysts plainly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Biomerica has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.72, suggesting that its stock price is 172% more volatile than the broader market.

Summary

Biomerica beats Innovative Eyewear on 8 of the 14 factors compared between the two stocks.

How does Biomerica compare to NexGel?

Biomerica (NASDAQ:BMRA) and NexGel (NASDAQ:NXGL) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

22.3% of Biomerica shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Comparatively, 23.4% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Biomerica currently has a consensus price target of $9.00, suggesting a potential upside of 452.15%. NexGel has a consensus price target of $2.00, suggesting a potential upside of 451.88%. Given Biomerica's higher probable upside, equities analysts plainly believe Biomerica is more favorable than NexGel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

NexGel has a net margin of -28.54% compared to Biomerica's net margin of -96.49%. NexGel's return on equity of -64.29% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-96.49%	-98.14%	-70.42%
NexGel	-28.54%	-64.29%	-29.64%

In the previous week, NexGel had 1 more articles in the media than Biomerica. MarketBeat recorded 1 mentions for NexGel and 0 mentions for Biomerica. Biomerica's average media sentiment score of 0.00 equaled NexGel'saverage media sentiment score.

Company	Overall Sentiment
Biomerica	Neutral
NexGel	Neutral

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$5.31M	0.95	-$4.97M	-$0.89	N/A
NexGel	$11.42M	0.29	-$3M	-$0.40	N/A

Biomerica has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, NexGel has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Summary

NexGel beats Biomerica on 12 of the 15 factors compared between the two stocks.

How does Biomerica compare to Cuprina Holdings (Cayman)?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends.

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	69.92	-$3.63M	N/A	N/A
Biomerica	$5.31M	0.95	-$4.97M	-$0.89	N/A

In the previous week, Cuprina Holdings (Cayman) had 1 more articles in the media than Biomerica. MarketBeat recorded 1 mentions for Cuprina Holdings (Cayman) and 0 mentions for Biomerica. Biomerica's average media sentiment score of 0.00 beat Cuprina Holdings (Cayman)'s score of -0.45 indicating that Biomerica is being referred to more favorably in the news media.

Company	Overall Sentiment
Cuprina Holdings (Cayman)	Neutral
Biomerica	Neutral

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
Biomerica	-96.49%	-98.14%	-70.42%

Biomerica has a consensus target price of $9.00, indicating a potential upside of 452.15%. Given Biomerica's higher probable upside, analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

22.3% of Biomerica shares are held by institutional investors. 18.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cuprina Holdings (Cayman) has a beta of -0.35, indicating that its share price is 135% less volatile than the broader market. Comparatively, Biomerica has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

Summary

Cuprina Holdings (Cayman) and Biomerica tied by winning 6 of the 12 factors compared between the two stocks.

How does Biomerica compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and Biomerica (NASDAQ:BMRA) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

Biomerica has a consensus price target of $9.00, indicating a potential upside of 452.15%. Given Biomerica's stronger consensus rating and higher probable upside, analysts plainly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Innovative Eyewear's average media sentiment score of 0.00 equaled Biomerica'saverage media sentiment score.

Company	Overall Sentiment
Innovative Eyewear	Neutral
Biomerica	Neutral

Innovative Eyewear has higher earnings, but lower revenue than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$2.98M	N/A	N/A	N/A	N/A
Biomerica	$5.31M	0.95	-$4.97M	-$0.89	N/A

Innovative Eyewear has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. Innovative Eyewear's return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	N/A	N/A	N/A
Biomerica	-96.49%	-98.14%	-70.42%

22.3% of Biomerica shares are owned by institutional investors. 18.0% of Biomerica shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Biomerica beats Innovative Eyewear on 5 of the 8 factors compared between the two stocks.

How does Biomerica compare to NEXGEL?

Biomerica (NASDAQ:BMRA) and NEXGEL (NASDAQ:NXGLW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

In the previous week, Biomerica's average media sentiment score of 0.00 equaled NEXGEL'saverage media sentiment score.

Company	Overall Sentiment
Biomerica	Neutral
NEXGEL	Neutral

NEXGEL has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. NEXGEL's return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-96.49%	-98.14%	-70.42%
NEXGEL	N/A	N/A	N/A

NEXGEL has higher revenue and earnings than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$5.31M	0.95	-$4.97M	-$0.89	N/A
NEXGEL	$11.27M	N/A	N/A	N/A	N/A

22.3% of Biomerica shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Biomerica presently has a consensus target price of $9.00, suggesting a potential upside of 452.15%. Given Biomerica's stronger consensus rating and higher probable upside, equities analysts clearly believe Biomerica is more favorable than NEXGEL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NEXGEL	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Biomerica and NEXGEL tied by winning 4 of the 8 factors compared between the two stocks.

Get Biomerica News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMRA vs. The Competition

Export

Metric	Biomerica	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.98M	$5.82B	$7.02B	$12.98B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-1.83	24.71	269.19	24.71
Price / Sales	0.95	61.03	588.76	86.26
Price / Cash	N/A	33.55	28.89	37.42
Price / Book	1.01	6.21	11.27	6.42
Net Income	-$4.97M	$147.87M	$3.45B	$347.03M
7 Day Performance	6.54%	3.40%	3.56%	2.49%
1 Month Performance	-3.55%	1.66%	-0.58%	-1.04%
1 Year Performance	-47.59%	6.26%	77.52%	23.22%

Biomerica Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMRA Biomerica	1.8789 of 5 stars	$1.63 +1.2%	$9.00 +452.1%	-47.1%	$4.98M	$5.31M	N/A	60
LUCY Innovative Eyewear	0.2926 of 5 stars	$0.74 +8.7%	N/A	-63.3%	$4.37M	$2.66M	N/A	9	Upcoming Earnings Gap Up
NXGL NexGel	2.0714 of 5 stars	$0.42 -0.5%	$2.00 +375.1%	-85.9%	$3.90M	$11.42M	N/A	10	News Coverage Upcoming Earnings Gap Up
CUPR Cuprina Holdings (Cayman)	0.6642 of 5 stars	$2.97 +2.8%	N/A	N/A	$2.66M	$40K	N/A	14	Gap Up
LUCYW Innovative Eyewear	N/A	$0.06 +48.5%	N/A	-20.5%	$0.00	$2.98M	N/A	9	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BMRA) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biomerica (BMRA) Competitors

BMRA vs. LUCY, NXGL, CUPR, LUCYW, and NXGLW

How does Biomerica compare to Innovative Eyewear?

Summary

How does Biomerica compare to NexGel?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Summary

How does Biomerica compare to Innovative Eyewear?

Summary

How does Biomerica compare to NEXGEL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biomerica (BMRA) Competitors

BMRA vs. LUCY, NXGL, CUPR, LUCYW, and NXGLW

How does Biomerica compare to Innovative Eyewear?

Which has higher earnings & valuation, BMRA or LUCY?

Do institutionals and insiders believe in BMRA or LUCY?

Is BMRA or LUCY more profitable?

Does the media refer more to BMRA or LUCY?

Do analysts prefer BMRA or LUCY?

Which has more volatility & risk, BMRA or LUCY?

Summary

How does Biomerica compare to NexGel?

Do insiders and institutionals have more ownership in BMRA or NXGL?

Do analysts recommend BMRA or NXGL?

Is BMRA or NXGL more profitable?

Does the media refer more to BMRA or NXGL?

Which has higher valuation & earnings, BMRA or NXGL?

Which has more risk & volatility, BMRA or NXGL?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Which has better valuation & earnings, CUPR or BMRA?

Does the media favor CUPR or BMRA?

Is CUPR or BMRA more profitable?

Do analysts recommend CUPR or BMRA?

Do insiders & institutionals have more ownership in CUPR or BMRA?

Which has more risk and volatility, CUPR or BMRA?

Summary

How does Biomerica compare to Innovative Eyewear?

Do analysts prefer LUCYW or BMRA?

Does the media favor LUCYW or BMRA?

Which has stronger valuation & earnings, LUCYW or BMRA?

Is LUCYW or BMRA more profitable?

Do institutionals & insiders believe in LUCYW or BMRA?

Summary

How does Biomerica compare to NEXGEL?

Does the media favor BMRA or NXGLW?

Is BMRA or NXGLW more profitable?

Which has better earnings and valuation, BMRA or NXGLW?

Do institutionals and insiders have more ownership in BMRA or NXGLW?

Do analysts recommend BMRA or NXGLW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools